SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001477932-21-002891
Filing Date
2021-05-06
Accepted
2021-05-06 10:43:41
Documents
32
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A insd_10qa.htm 10-Q/A 23449
2 CERTIFICATION insd_ex311.htm EX-31.1 9541
3 CERTIFICATION insd_ex321.htm EX-32.1 4044
  Complete submission text file 0001477932-21-002891.txt   678389

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT insd-20210228.xml EX-101.INS 64157
5 XBRL TAXONOMY EXTENSION SCHEMA insd-20210228.xsd EX-101.SCH 14639
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE insd-20210228_lab.xml EX-101.LAB 83401
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE insd-20210228_cal.xml EX-101.CAL 17609
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insd-20210228_pre.xml EX-101.PRE 68537
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE insd-20210228_def.xml EX-101.DEF 24331
Mailing Address 1545 CROSSWAYS BLVD. SUITE 250 CHESAPEAKE VA 23320-0218
Business Address 1545 CROSSWAYS BLVD. SUITE 250 CHESAPEAKE VA 23320-0218 800-542-8715
Instadose Pharma Corp. (Filer) CIK: 0001697587 (see all company filings)

IRS No.: 813599639 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q/A | Act: 34 | File No.: 333-216292 | Film No.: 21896387
SIC: 2510 Household Furniture